Infant Phototherapy Device Market Report by Light Source (Fluorescent Lamps, Light Emitting Diodes, Quartz Halogen Lamps, Gas Discharge Tubes), Configuration (Mobile Device, Fixed Device), End User (Hospitals, Neonatal Clinics), Country and Company Analys

Infant Phototherapy Device Market Report by Light Source (Fluorescent Lamps, Light Emitting Diodes, Quartz Halogen Lamps, Gas Discharge Tubes), Configuration (Mobile Device, Fixed Device), End User (Hospitals, Neonatal Clinics), Country and Company Analysis 2024-2032

Infant Phototherapy Device Market size is expected to be about US$ 135.97 Million by 2032 compared to US$ 96.44 Million in 2023. Renub Research states that Infant Phototherapy Devices Industry to grow with a CAGR of 3.89% from 2024 to 2032.

Visible light is used in phototherapy to treat severe jaundice in newborns. To avoid the neurotoxic effects of elevated serum unconjugated bilirubin, phototherapy is used as a treatment. Exchange transfusion is not as necessary in newborns when phototherapy is used, as it is a safe and effective way to lower or stop the rise of serum unconjugated bilirubin levels. When it comes to phototherapy, blue-green light works best since it can enter the skin and be absorbed by bilirubin, which produces a photochemical effect.

Infant Phototherapy Device Market Trends
• Prevalence of Jaundice in Newborns

An infant with elevated blood bilirubin levels is said to be jaundiced. The body produces bilirubin, a yellow substance, as it replaces broken red blood cells. Newborns with high bilirubin levels can suffer severe consequences if they are not recognized and treated. Newborns are more likely to have jaundice because their blood contains more red blood cells than other blood types. The whites of the eyes and skin can become yellow due to jaundice, although sometimes it is difficult to see the symptoms, especially in premature or newborn babies with brown or black skin. According to a BMJ Journals article, during the first week of life, 60% of term and 80% of preterm infants experience neonatal jaundice. The incidence of jaundice is adding to the growth in the global infant phototherapy device market.
• Assistance of Home-based Phototherapy expands the Infant Phototherapy Device Market

A distinctive feature of the newborn stage is the unbreakable bond between a mother and her child. The hospitalization of their infant or child, however, is one of the most painful events in a parent's life and can have a significant impact on their life. Hospitalization for phototherapy within the first few days of life might lead to issues such as nosocomial infections. It is possible to recommend home phototherapy as a risk-free treatment option for patients with no side effects. As a result, it is boosting the global infant phototherapy device market. It is a more reasonable choice as well. The NIH stated that the average cost reductions per patient were €819 (95% confidence interval €613-1025) or 71% when comparing the cost per patient of home phototherapy to the hospital alternative, which was €1156.
• Technological Advancements and Innovation in the Infant Phototherapy Device Industry

The market for infant phototherapy is expanding as a result of novel ways to treat neonatal hyperbilirubinemia that have been made possible by technological advancements in phototherapy. A noteworthy research area is LED phototherapy, which has been the focus of studies assessing its effectiveness in treating unconjugated hyperbilirubinemia. Home phototherapy (HPT) devices at a low cost have been created to increase accessibility, especially in developing nations. A couple of examples include the Brilliance jaundice treatment device and the Iranian HPT system, which are intended to provide affordable options for phototherapy in homes. These devices are designed to overcome gaps in healthcare access, especially in areas where implementing standard hospital-based phototherapy may be difficult. Another interesting advancement is the use of LED panels into a phototherapy system. Wearable phototherapy has being investigated by researchers as a cutting-edge strategy for driving innovation. Neonatal care is undergoing revolutionary changes through the adoption of varied methodologies, with the goal of improving treatment accessibility, efficacy, and patient experience.

United States Infant Phototherapy Device Market

The United States might have a considerable share in the global infant phototherapy device market. This is due to the prevalence of neonatal jaundice. A JAMA Network report states that between 60% and 70% of the 4 million babies born in the United States each year have clinical jaundice. The consumer awareness initiatives further propel the worldwide infant phototherapy device industry. For example, in 2023, the International Society for Neonatal Screening (ISNS) and the Association of Public Health Laboratories (APHL) joined forces to showcase global advancements and possibilities in neonatal screening.

The high rate of diagnosis and treatment and technological advancements further drive the infant phototherapy device market. For example, the FDA-approved ""SkyLife"" device, which is now under examination, is a mattress that uses blue LEDs as its light source, just like the existing blue LED panel devices. Because it produces safer, non-ultraviolet light, this gadget is thought to prevent many of the ill effects associated with using fluorescent tube lights. It is also more efficient than using mattresses or blankets, which rely on fluorescent tubes or blue halogen bulbs for lighting. The light is emitted under the infant.

Infant Phototherapy Device Industry News

A few well-known businesses in the global market for baby phototherapy devices exist. These include Inspiration Healthcare Group Plc, Drägerwerk AG & Co. KGaA, Ningbo David Medical Device Co., Ltd., Koninklijke Philips N.V., General Electric Company, Ibis Medical Equipment and Systems Pvt Ltd., Weyer GmbH, and Natus Medical Incorporated.
• In December 2023- 2nd hospital in Rajkot has a particular neonatal care unit. Officials added that the ten-bed unit has all modern equipment for treating neonatal patients. These include LED phototherapy equipment for treating neonatal jaundice.
• In November 2023- Drager declared that it had won financing from the Innovative Health Initiative and is moving forward with creating an intensive-care unit in collaboration with technology partners.
• In September 2022- Bangalore-based GenWorks developed Billicare, a noninvasive (blood is drawn without the need for needles or pins) technology that measures a baby's bilirubin levels by fastening a clip to their ears.
• In June 2021- The BiliTouchTM Phototherapy Blanket was introduced by an insurance-eligible manufacturer of modern motherhood products. The BiliTouchTM is designed to treat newborns with hyperbilirubinemia, also called neonatal jaundice. It is battery-operated, ultraportable, and lightweight, making it suitable for home and hospital use.

Light Source – Market breakup in 3 viewpoints:

1. Fluorescent Lamps
2. Light Emitting Diodes
3. Quartz Halogen Lamps
4. Gas Discharge Tubes

Configuration – Market breakup in 2 viewpoints:

1. Mobile Device
2. Fixed Device

End User – Market breakup in 2 viewpoints:

1. Hospitals
2. Neonatal Clinics

Country – Market breakup of 25 Countries:

1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey

3. Asia Pacific

3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America

4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East & Africa

5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

All the key players have been covered from 4 Viewpoints:
• Overview
• Product Portfolio
• Recent Development
• Revenue Analysis

Key Players Analysis:

1. Ningbo David Medical Device Co.
2. Ltd, Koninklijke Philips N.V.
3. General Electric Company
4. Inapiration Healthcare Group Plc
5. Drägerwerk AG & Co. KGaA
6. Ibis Medical Equipment and Systems Pvt Ltd.
7. Weyer GmbH
8. Natus Medical Incorporated.